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Abstract 
For ethical reasons, the use of experimental animals for skin irritation studies is not desired, mainly for cosmetical products. 
Alternative methods for skin irritation testing have been proposed, but no method has been yet successfully pre validated. Then, 
the research centers have searched alternative methods. We demonstrated the viability of ex vivo model of human skin (hOSEC: 
HUMAN ORGANOTYPIC SKIN EXPLANTED CULTURE) by proliferative capacity of skin keratinocyte for up to 75 days in 
culture and compared it to in vivo models (hairless and human), proving hOSEC method as an alternative for secure and efficacy 
tests of sun protection factor. 
© 2015 The Authors. Published by Elsevier Ltd. 
Peer-review under responsibility of IDMEC-IST. 
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1. Introduction 
A large number of animals, especially rabbits, are still used to test the dermal irritancy of chemical compounds [1]. 
For ethical reasons the use of experimental animals for skin irritation studies is not desired, mainly for cosmetical 
products. A number of alternative methods for skin irritation testing have been proposed and several have been 
evaluated in an ECVAM (European Centre for the Validation of Alternative Methods) for pre validation trial, but no 
method has been yet successfully pre validated [2]. Some of them are human keratinocytes culture to analyze the 
metabolism of dimethyl-thiazoldiphenyltetrazolium bromide (MTT) or by leakage of lactate dehydrogenase (LDH) 
from cells or neutral red from preloaded cells [3-5]. However, some disadvantages are considered as these analyses 
should be made in a short time using only diluted products or chemical in culture medium. Additionally, these models 
there are no skin resurfacing to receive topical products directly, like in vivo using. 
The hOSEC (human organotypic skin explanted culture) constitutes a model close to in vivo human skin, as a 3D 
human skin model, consisting entirely of melanocytes, Langerhans cells, keratinocytes, and the whole structure of 
dermal fibroblasts, glycosaminoglycans and collagen, ideal for laboratory testing. Such features are become essential 
for its differentiation from the existing three-dimensional validated models, which are made only of keratinocytes and 
fibroblasts on a devitalized extracellular matrix. By presenting an airliquid interface, the system hOSEC allows the 
application of creams, ointments and lipid-soluble substances on the horny layer that keeps the different cell culture 
systems that only allow the use of soluble substances in the culture medium and the absence of stratum corneum [6-
9]. 
Considering the complete structure of hOSEC as a human skin, this model seems appropriated for test of topical 
cutaneous products like sunscreens. Some authors have used hOSEC model to analyze cell migration into the skin 
after chemical sensitization, and others evaluate it by keratinocyte cytotoxicity measuring the disappearance of 
keratinocyte RNA, which was visualized using a modified methyl green-pyronine (MGP) stain [6-9]. Although these 
studies have showed the viability of the model, none of them have showed the viability longer than 3 weeks neither 
the proliferative capacity of the explanted skin. 
Thus, the purpose of this study was to demonstrate the viability of hOSEC model by proliferative capacity of the 
keratinocyte of skin for up to 75 days in culture and to compare the hOSEC model to in vivo models (hairless and 
human), to confirm hOSEC as an alternative model for secure and efficacy tests of cosmetics. 
 
2. Method 
2.1. Viability of hOSEC for 75 days in culture 
Skin was obtained with the informed consent of patients undergoing either breast or abdomen reduction surgery, 
in accordance with the ethical guidelines of the Research Ethics Committee of the Clinics Hospital of School of 
Medicine of Ribeirao Preto, University of Sao Paulo (protocol number 1669/2014). 
The explants were cut (1.0 cm2) and it were cultured on metal grids into standard 6-well plates in contact with 
culture medium at 37°C in 5% CO2 humidified air. The culture media consist of Dulbecco's Modified Eagle Medium 
(DMEM) with 10% Fetal Bovine Serum (Sigma-Aldrich, Germany), 1% anti-anti (10.000 units penicillin, 10 mg 
streptomycin and 25 μg amphotericin B - Sigma-Aldrich, Germany) and 1% L-glutamine (Sigma-Aldrich, Germany). 
After 1, 7, 30 and 75 days in culture, the explants were harvested, fixed in formalin, embedding in paraffin and 
followed the histology and immunohistochemistry methods [9, 10]. 
 
2.1.1. Histology 
Paraffined sections (3.0 μm) were stained with hematoxylin eosin (HE) for histomorphological analysis. Changes 
in epidermal morphology was followed by qualitative analysis using LEICA® DM-4000B optical microscope with 
camera LEICA® DFC 280 connected to the computer with the software LAS® - Leica Application for capturing images 
(Leica Microsystems,Germany) [10]. 
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2.1.2 Immunohistochemistry 
Three-micrometer paraffin sections were subjected to antigen retrieval by autoclaving in citrate buffer, pH 6.0, for 
5 minutes. Endogenous peroxidase was blocked with 3% hydrogen peroxide in PBS followed by nonspecific blocking 
with 1% BSA. The sections were incubated with the primary antibody in 1% BSA overnight at 4°C. The antibodies 
used were mouse anti-human Ck5/6 (1:100 dilution), Ck10 (1:100) and Ki-67 (1:100) (Santa Cruz Biotechnology, 
USA). NovoLink Polymer Detection System Kit (Novocastra Laboratories Ltd, Newcastle Upon Tyne, UK) was used. 
The color reaction was developed by 3,3 diaminobenzidine tetrahydrochoride (Sigma-Aldrich, Germany). The 
sections were counterstained with Mayer’s hematoxylin and mounted in Entelan (Sigma-Aldrich, Germany). The 
expression of Ck5/6 (basal cells of epidermis), Ck10 (stratum corneum) and Ki-67 (proliferative keratinocyte) were 
analyzed qualitatively only on 75 day of follow-up [10]. 
2.2. hOSEC model x in vivo models (hairless and human) 
To compare hOSEC model (in vitro) with in vivo models (hairless mouse and human) by photodamage effect, the 
hOSEC method was performed as related before, but the explants were exposed at UVA radiation (450W) by 8 
minutes, during currently 7 days. The explants were organized in experimental groups according to the topic treatment: 
PHYSIC, explanted treated with physic filter sunprotector [FORMULATION: 10% zinc oxide, 10% titanium dioxide, 
lotion croda]; VEHICLE, [FORMULATION: lotion croda] treated with only vehicle of physic filter; and SHAM, no 
filter. At the day 8, the explants were harvested at the same time and it were performed immunohistological process 
to evaluate the number of necrotic keratinocytes, p53 (apoptosis) and Ki-67 (viable/proliferation) compare to non-
exposed skin to UVA radiation.  
The same method was performed on the back of hairless mice, organized at the same experimental groups 
(PHYSIC, VEHICLE and SHAM – n=5/group).  
In humans participants (n=5), it was applied the light on the back (like on hOSEC and hairless methods) each back 
area for each corresponding treatment: PHYSIC, VEHICLE and SHAM, and photographed the erythema on irradiated 
region after 8 days of flowed-up. 
3. Results 
3.1. Viability of hOSEC for 75 days in culture 
3.1.1 Histological evaluation 
Histologically, the hOSEC model showed viable on 7th day because the epidermis looked like of the 1st day and 
maintaining the dermo-epidermal junction perfectly linked. Besides, on the 7th day, the epidermis showed with basal, 
spinous, granular and thick horny layers. No chances was observed on the dermis. On 30th day, the epidermis was 
thicker with less spinous layers but the cutaneous structure was maintained the same, able to application of topical 
products. On the 75th day, the skin grow thinner, but the dermo-epidermal junctions was also maintained and with 
epidermis proliferation (Figure 1) [10]. 
 
3.1.2 Immunohistochemical evaluation 
By immunohistochemistry, after 75th day on culture the skin showed similar to a normal skin with lapelled 
keratinocytes by Ck5/6 on supra-basal layers; Ck10 on differentiated layers; and the viability can be proved by the 
positivity of basal cells by Ki-67 showing the proliferation and viability capacities of keratinocytes (Figure 2) [10]. 
 





















Fig. 1. Hematoxylin eosin staining of skin on culture for 1, 7, 30 and 75 days proving the viability of hOSEC method by proli ferative capacity of 
eratinocytes (magnification: 100x and 400x) [10]. 
 
Fig. 2. Immunohistochemical staining of skin on culture for 75 days for Ck5/6, Ck10 and Ki-67 proving the viability of hOSEC method by 
proliferative capacity of keratinocytes (magnification: 100x and 400x) [10]. 
 
3.2. hOSEC model x in vivo models (hairless and human) 
The PHYSIC filter showed important effect photoprotector on skin, different to VEHICLE and SHAM treatments, 
that showed higher necrotic keratinocytes and p53 (apoptosis) on irradiated area. The skin cells on culture maintained 
viable during 8 days of flowed-up, according to the stained for Ki-67, specially on no-irradiated area and on area 
treated with PHYSIC filter (Figure 3).  
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Fig. 3. Comparison of three methods: (A, D, F) hOSEC model, (B, E, G); hairless and (C) human in vivo models. (A, B) amount of necrotic 
keratinocyte; (C) photography of irradiated area (IR) and no irradiated area (N-IR) of human dorsal skin treated with PHYSIC filter (P), 




Tests conducted on animals for cosmetics were banned in several countries and industries related to this practice 
suffered serious limitations [7, 10]. Then, research centers are searching to develop alternative methods for animal 
use. 
The hOSEC is a system of human skin in culture which is closest to in vivo condition because it maintains all skin 
structure as melanocytes, Langerhans cells, keratinocytes, and the whole structure of dermal fibroblasts, 
glycosaminoglycans and collagen [7,10]. Because of these aspects, it seems be able to evaluate the safety and efficacy 
of topical products, as sunscreens for example [8, 10] besides retains important elements of in vivo skin showing 
significant advantages for in vitro wound healing studies [9, 10]. It was initially described on studies of allergic contact 
dermatitis in up to 3 weeks in culture [8, 10] 
The present study demonstrated the cell viability/vitality of human skin fragments in culture for 75 days. The 
viability of the hOSEC model was proved by the maintaining of dermo-epidermal junction and epidermal proliferation 
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according histological and immunohistochemical data for Ck5/6, Ck10 and the Ki-67 proliferation marker. Thus, this 
method is feasible for use in cosmetic tests up to 75 days. Moreover, its implementation is faster and less expensive 
than available in vitro systems. 
However, this model has some limitations like lack of innervation and circulation. Integration of blood vessels or 
the equivalent has been the subject of extensive research [10-12]. 
Communication in the skin is mediated by cytokines, neurotransmitters, hormones, growth factors and eicosanoids 
which can be added to the culture medium, but cell-cell interactions also appear to be necessary [7, 10] 
The presence of all epidermal and dermal cellular types, immune cells such lymphocytes, dendritic cells, 
macrophages, and conservation of the in vivo structure and physiology has permitted the use of skin explant in a large 
panel of diseases and processes including immune disease, wound healing, the extracellular matrix process, ageing, 
cancer and cosmetic tests. Furthermore, it represents a good tool to understand physiopathology, and the lack of 
contact with the organism may be compensated by the addition of many substances. It remains the most representative 
in vitro model of human skin [7, 10]. 
The present study also demonstrated the hOSEC model as an alternative method for experimental animal use, 
especially for cosmetics tests (sun protection factor). To validate this capacity, we compared the same methodology 
performed of skin damage (by UVA radiation - 450W) and protection (by physic filter) on human skin explanted (in 
vitro method - hOSEC) and on dorsal skin of hairless mouse and human (in vivo methods). 
The level of aggression caused by UVA light on skin was seen by necrosis of keratinocytes. Then, the amount of 
necrotic keratinocytes was similarly between hOSEC and hairless model, showing that the damage on skin and the 
skin protection by physic filter was similar on both methods (Figure 3A).  
It was used for analysis of viability the immunohistochemistry of Ki-67. Dividing cells express the nuclear protein 
Ki-67 during G1 S , G2, and M division phases. Therefore, this protein has been used in the study of cell proliferation 
and pathology of tumors and cancers [13, 14]. Thus, it can be considered that on the absence of protection by physic 
filter the proliferating of cells was lower on hOSEC model compare to hairless model due to the lack of systemic 
renovation of cells on hOSEC. This can be seen by low amount of Ki-67 on VEHICLE and SHAM irradiated, different 
to hairless model. Moreover, the PHYSIC filter showed your important sun protector capacity, highlighted by more 
proliferation of cells (Figure 3D-E). 
The tumor suppressor protein - p53 has been recognized as a critical cell controller in response to stress (in the 
case of this work, the stress is caused by UVA light and the skin condition to be maintained in culture in hOSEC 
model), including various types of DNA damage [15, 16]. Only this status is sufficient to differ the p53 profile on 
hOSEC model to hairless model. 
In hOSEC model, S-IR group showed a higher percentage of p53 compared to P-IR and V-IR (p <0.05), similarly 
to S N-IR group was higher than the V N-IR group, indicating that physic filter and vehicle served with barrier to 
protect from the damaging effects of UVA light, and, similarly to Ki-67, it is not observed alterations on skin oh 
hairless model by the systemic renovation of cells (Figure 3F-G). These data corroborate the Ki-67, which the 
photoprotection is important to not to alter the viability and cell proliferation. However, the absence of photoprotection 
cause harmful effects of light, for example, increased apoptosis by increasing p53. 
On dorsal skin of human participants, we could see the effectiveness of sunscreen physic filter used in comparison 
to your vehicle cream and sham, similar to hOSEC and hairless models (Figure 3C). 
Thus, besides hOSEC model was viable for up to 75 days, it showed similar skin damage and protection to in vivo 
model (hairless mouse), suggesting the hOSEC model as an alternative to animal and human for sun protection tests. 
5. Conclusion 
The hOSEC model seems a good alternative method to animal model testing and can be used as a pre-clinical 
cosmetic test similar to clinical human skin test (and also hairless mice) with comparable viability, confirmed by 
immunohistological analyses. 
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